Effect of acute administration of sildenafil to rats with detrusor overactivity induced by chronic deficiency of nitric oxide

Effect of acute administration of sildenafil to rats with detrusor overactivity induced by chronic deficiency of nitric oxide

Purpose Recently, the effect of phosphodiesterase inhibitors (PDE5i) in the lower urinary tract symptoms (LUTS) associated to benign prostatic hyperplasia have been studied thoroughly. However, it remains unclear how the PDE5i improve LUTS. Therefore, the aim of the present study was to evaluate the...

Full description

Bibliographic Details
Main Authors:	Ricardo Reges, Carlos D'ancona, Fabíola Mônica, Edson Antunes
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2013-04-01
Series:	International Brazilian Journal of Urology
Subjects:	sildenafil nitrate [Supplementary Concept] Nitric Oxide Lower Urinary Tract Symptoms
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382013000200268

Similar Items

Efficacy and safety of propiverine and terazosine combination for one year in male patients with luts and detrusor overactivity
by: Nevzat Can Sener, et al.
Published: (2013-07-01)

Does sildenafil enhance the effect of tamsulosin in relieving acute urinary retention?
by: Seyed Hossein Hosseini Sharifi, et al.
Published: (2014-06-01)

Detrusor underactivity versus bladder outlet obstruction clinical and urodynamic factors
by: Jefferson Kalil, et al.
Published: (2020-03-01)

Evaluation of the effect of sildenafil and/or doxazosin on Benign prostatic hyperplasia-related lower urinary tract symptoms and erectile dysfunction
by: Ahmed Abolyosr, et al.
Published: (2013-01-01)

Improved model for the establishment and evaluation of detrusor overactivity in female Wistar rats
by: Nian-zhao Zhang, et al.
Published: (2014-06-01)

Efficacy of Tamsulosin, Oxybutynin, and their combination in the control of double-j stent-related lower urinary tract symptoms
by: Miguel Maldonado-Avila, et al.
Published: (2016-06-01)

Flowmetry/pelvic floor electromyographic findings in patients with detrusor overactivity
by: Farshid Alizadeh, et al.
Published: (2015-06-01)

Clinical Outcome in Male Patients With Detrusor Overactivity With Impaired Contractility
by: Shuo Liu, et al.
Published: (2014-09-01)

Improvement of Persistent Detrusor Overactivity through Treatment with a Phytotherapeutic Agent (WSY-1075) after Relief of Bladder Outlet Obstruction
by: Su Jin Kim, et al.
Published: (2018-05-01)

Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivity
by: Quentin Ballouhey, et al.
Published: (2015-12-01)

Interim Guidance for Urodynamic Practice during COVID-19 Pandemic
by: André Avarese Figueiredo, et al.
Published: (2020-11-01)

Updates of Overactive Bladder in Pediatrics
by: Jisung Shim, et al.
Published: (2023-03-01)

Sildenafil Effect on Nitric Oxide Secretion by Normal Human Endometrial Epithelial Cells Cultured In vitro
by: Mozafar Khazaei, et al.
Published: (2011-10-01)

Does uroflowmetry parameter facilitate discrimination between detrusor underactivity and bladder outlet obstruction?
by: Kwon Soo Lee, et al.
Published: (2016-11-01)

Defining Voiding Dysfunction in Women: Bladder Outflow Obstruction Versus Detrusor Underactivity
by: Konstantinos-Vaios Mytilekas, et al.
Published: (2021-09-01)

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

PDE5 Inhibitor Treatment Persistence and Adherence in Brazilian Men: Post-hoc Analyses from a 6-Month, Prospective, Observational Study
by: Carlos Cairoli, et al.
Published: (2014-06-01)

Detrusor Overactivity May Be a Prognostic Factor for Better Response to Combination Therapy Over Monotherapy in Male Patients With Benign Prostatic Enlargement and Storage Lower Urinary Tract Symptoms
by: Vasileios Sakalis, et al.
Published: (2021-03-01)

Monitoring bladder compliance using end filling detrusor pressure: Clinical results and related factors
by: Jin-Yi Liao, et al.
Published: (2015-12-01)

The Prevalence of Lower Urinary Tract Symptoms and Overactive Bladder in South Korea: A Cross-Sectional, Population-Based Study
by: Myung Ki Kim, et al.
Published: (2022-03-01)

Correlation between overactive bladder symptom score and neuropsychological parameters in Alzheimer’s disease patients with lower urinary tract symptom
by: Ha Bum Jung, et al.

Hypothesis of COVID-19 therapy with sildenafil
by: Limodio Mario, et al.
Published: (2020-01-01)

The Impact of Combined Oral Sildenafil and Inhaled Nitric Oxide for Treating Persistent Pulmonary Hypertension of the Newborn: A Single Center Experience
by: Hayriye Gozde Kanmaz, et al.
Published: (2017-08-01)

Administration of BAY 41-2272 prevents bladder dysfunction in nitric-oxide deficient rats
by: Carlos Arturo Levi D’Ancona, et al.
Published: (2010-12-01)

Administration of BAY 41-2272 prevents bladder dysfunction in nitric-oxide deficient rats
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2010-12-01)

Diagnostic Tool for Assessing Overactive Bladder Symptoms: Could the International Prostate Symptom Storage Subscore Replace the Overactive Bladder Symptom Score?
by: Ji Sung Shim, et al.
Published: (2016-09-01)

Effects of High Salt Intake on Detrusor Muscle Contraction in Dahl Salt-Sensitive Rats
by: Ryoya Kawata, et al.
Published: (2021-02-01)

Impact of Overactive Bladder Syndrome on Female Sexual Function
by: Serdar Toksöz, et al.
Published: (2015-12-01)

Prevalence of detrusor underactivity and bladder outlet obstruction in women with cystocele and changes in voiding function after cystocele repair
by: Ting-Chen Chang, et al.
Published: (2020-12-01)

The Relationship between the Presence of an Earlobe Crease and Overactive Bladder: A Cross-Sectional Case-Controlled Study
by: Yasufumi Ueda, et al.
Published: (2023-02-01)

Evaluating TIMP-2 and IGFBP-7 as a predictive tool for kidney injury in ureteropelvic junction obstruction
by: Marcos Figueiredo Mello, et al.
Published: (2022-03-01)

The Prevalence of Detrusor Underactivity and its Symptoms Co-relation with Urodynamic Study Findings in Patients with Lower Urinary Tract Symptoms
by: Sawaqed F, et al.
Published: (2020-09-01)

Comparison of intravenous sildenafil with inhaled nitric oxide for acute vasodilator testing in pulmonary arterial hypertension
by: Shine Kumar, et al.
Published: (2022-10-01)

Is There a Link Between Carotid Atherosclerosis and Idiopathic Overactive Bladder Among Women with Metabolic Syndrome?
by: Schimit GTF, et al.
Published: (2020-02-01)

‘Tamsulosin and Darifenacin’ Versus ‘Tamsulosin Monotherapy’ for ‘BPH with Accompanying Overactive Bladder’
by: IQBAL SINGH, et al.
Published: (2015-06-01)

INTERSTITIAL CYSTITIS AS A PLAUSIBLE CAUSE OF OVERACTIVE BLADDER IN SYSTEMIC SCLEROSIS: A HYPOTHESIS
by: Neslihan Gokcen
Published: (2022-08-01)

Predicting Refractory Detrusor Overactivity: Are There any Clues at Diagnosis
by: Kylie J Mansfield, et al.
Published: (2013-12-01)

Retinal effects of Sildenafil in diabetic patients
by: Abdul-Razzak Bahir
Published: (2008-04-01)

Editorial: Benign prostatic hyperplasia and overactive bladder: new members of metabolic syndrome
by: Xiaolong Wang, et al.
Published: (2023-08-01)

Lower Urinary Tract Symptoms and Overactive Bladder in a Large Cohort of Older Poles—A Representative Tele-Survey
by: Mikolaj Przydacz, et al.
Published: (2023-04-01)